title: Voriconazole in newborns.
abstract: Voriconazole is a newer systemic antifungal agent effective against Candida and Aspergillus. There are few reports of its safe use in newborns. We report the first case series of safe Voriconazole use in critically ill newborns with cardiac disease along with several other cardiac drugs without any significant drug interaction or side-effect.
authors: Apollo Center for Advanced Pediatrics, Pediatric Cardiology and Cardiac Surgery Unit, Indraprastha Apollo Hospital, New Delhi, India. vkohli_md@yahoo.com
authors: Vikas
authors: V
authors: Kohli
authors: Vikas
authors: V
authors: Taneja
authors: Poonam
authors: P
authors: Sachdev
authors: Raja
authors: R
authors: Joshi
mesh_terms: D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001230:Aspergillus / Q000187:drug effects*; D002175:Candida / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy*; D016638:Critical Illness; D006801:Humans; D007231:Infant, Newborn; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole